Related Experiment Video
Updated: Apr 25, 2026

Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants
Published on: August 5, 2021
Modified titanium implant as a gateway to the human body: the implant mediated drug delivery system
Young-Seok Park1, Joo-Youn Cho2, Shin-Jae Lee3
1Department of Oral Anatomy, Seoul National University School of Dentistry and Dental Research Institute, Seoul 110-749, Republic of Korea ; Department of Oral and Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, FL 32610, USA.
Abstract:
The aim of this study was to investigate the efficacy of a proposed new implant mediated drug delivery system (IMDDS) in rabbits. The drug delivery system is applied through a modified titanium implant that is configured to be implanted into bone. The implant is hollow and has multiple microholes that can continuously deliver therapeutic agents into the systematic body. To examine the efficacy and feasibility of the IMDDS, we investigated the pharmacokinetic behavior of dexamethasone in plasma after a single dose was delivered via the modified implant placed in the rabbit tibia. After measuring the plasma concentration, the areas under the curve showed that the IMDDS provided a sustained release for a relatively long period. The result suggests that the IMDDS can deliver a sustained release of certain drug components with a high bioavailability. Accordingly, the IMDDS may provide the basis for a novel approach to treating patients with chronic diseases.
More Related Videos
Related Concept Videos
Intrauterine Drug Delivery Systems
Transdermal Drug Delivery Systems
Modified-Release Drug Delivery Systems: Site-Targeted
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Modified-Release Drug Delivery Systems: Rate-Programmed II
Drug Delivery Systems: Different Types

